Appelbaum is one of two deputy directors at Fred Hutch; Mark T. Groudine, M.D., Ph.D., former director and member of the Hutch's Basic Sciences Division, has served as deputy director since 1997 and executive vice president of the Hutch since 2005.
"Mark will continue to devote himself to the complex array of issues that involve faculty and staff, and he will continue to represent the Hutch on the SCCA board," Corey said.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch's pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation's first and largest cancer prevention research program, as well as the clinical coordinating center of the Women's Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit www.fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.
CONTACT Kristen Woodward firstname.lastname@example.orgSOURCE Fred Hutchinson Cancer Research Center